- Home
- IART
IART
Integra LifeSciences Holdings Corporation
as 05-09-2025 4:00pm EST
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | PRINCETON |
| Market Cap: | N/A | IPO Year: | 1995 |
| Target Price: | $19.43 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Hold | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.38 | EPS Growth: | N/A |
| 52 Week Low/High: | $11.60 - $32.66 | Next Earning Date: | 05-05-2025 |
| Revenue: | $1,624,308,000 | Revenue Growth: | 6.19% |
| Revenue Growth (this year): | 6.36% | Revenue Growth (next year): | 4.32% |
Latest Integra LifeSciences Holdings Corporation News
IART Breaking Stock News: Dive into IART Ticker-Specific Updates for Smart Investing
StockStory
3 days ago
Q1 Earnings Highlights: Teleflex (NYSE:TFX) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
StockStory
3 days ago
Q1 Earnings Highs And Lows: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
Simply Wall St.
4 days ago
Integra LifeSciences Holdings First Quarter 2025 Earnings: EPS Misses Expectations
Zacks
4 days ago
Integra Q1 Earnings Miss Estimates, Stock Down, '25 EPS Outlook Cut
GuruFocus.com
4 days ago
Integra Lifesciences Holdings Corp (IART) Q1 2025 Earnings Call Highlights: Navigating ...
Thomson Reuters StreetEvents
4 days ago
Q1 2025 Integra Lifesciences Holdings Corp Earnings Call
MT Newswires
4 days ago
Top Midday Decliners
StockStory
4 days ago
Why Integra LifeSciences (IART) Shares Are Getting Obliterated Today
Compare IART vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IART Integra LifeSciences Holdings Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.